TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Also NIH institute directors earn higher salaries than Vice President Cheney; House subcommittee investigating pay of top NIH officials. February 6, 2004